|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-5-14
|
|
pubmed:abstractText |
Cancer of unknown primary (CUP) lacks established therapy although it affects 3% of cancer patients. We evaluated the irinotecan-oxaliplatin combination (IROX regimen) in previously untreated patients with non-favorable subsets of unknown primary carcinomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
pubmed-author:AravantinosGG,
pubmed-author:BamiasAA,
pubmed-author:BriasoulisEE,
pubmed-author:DimopoulosM AMA,
pubmed-author:FountzilasGG,
pubmed-author:KalofonosHH,
pubmed-author:MakatsorisTT,
pubmed-author:MylonakisNN,
pubmed-author:PapakostasPP,
pubmed-author:PavlidisNN,
pubmed-author:SamantasEE,
pubmed-author:SkarlosDD,
pubmed-author:VarthalitisII,
pubmed-author:XirosNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
277-84
|
|
pubmed:meshHeading |
pubmed-meshheading:17901952-Adenocarcinoma,
pubmed-meshheading:17901952-Adult,
pubmed-meshheading:17901952-Aged,
pubmed-meshheading:17901952-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17901952-Camptothecin,
pubmed-meshheading:17901952-Disease-Free Survival,
pubmed-meshheading:17901952-Drug Administration Schedule,
pubmed-meshheading:17901952-Female,
pubmed-meshheading:17901952-Humans,
pubmed-meshheading:17901952-Male,
pubmed-meshheading:17901952-Middle Aged,
pubmed-meshheading:17901952-Neoplasms, Unknown Primary,
pubmed-meshheading:17901952-Organoplatinum Compounds
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
|
|
pubmed:affiliation |
Ioannina University Hospital, Ioannina, Greece. ebriasou@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
